BioPharma Pharma QC
The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...
February 06, 2024 | News
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...
January 26, 2024 | News
Molecule AI, on a mission to accelerate drug discovery through the innovative use of artificial intelligence, is making significant...
January 20, 2024 | News
The approval is based on the positive results of the pivotal Phase III ReSTORE clinical trial and is supported by STRIVE's Phase II clinical trials and a...
January 01, 2024 | News
The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...
January 01, 2024 | News
Goldenseal is one well-known example of a berberine-rich plant and enjoys a long history of medicinal use by Native American tribes. Berberine has rece...
December 27, 2023 | News
Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...
December 22, 2023 | News
In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...
December 15, 2023 | News
The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...
December 07, 2023 | News
Leading GMP cell CDMO I Peace, Inc. , specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that its&...
December 07, 2023 | News
Daewoong Pharmaceutical, represented by CEO Seng-ho Jeon and Chang-Jae Lee, proudly announced that their Osong factory passed the Brazilian Good Manuf...
November 28, 2023 | News
Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...
November 24, 2023 | News
By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...
November 23, 2023 | News
Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials Allows Pharma QC/QA and R&...
November 16, 2023 | News
Most Read
Bio Jobs
News
Editor Picks